Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Christchurch United Kingdom (2005)

Organization Overview

First Clinical Trial
2007
NCT00467636
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Royal Bournemouth Hospital NHS Trust | Royal Bournemouth Hospital UK | The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Active Ingredients

Drugs in Phase 4 Trials (2)

midazolam (versed) (1 trial)

nitrous oxide (1 trial)

Drugs in Phase 3 Trials (1)

xilonix (1 trial)

Drugs in Phase 2 Trials (1)

cannabidiol (Epidiolex) (1 trial)

Drugs in Other Trials (3)

acetic acid (vosol) (1 trial)

caffeine (1 trial)

insulin glulisine (Apidra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cachexia (Phase 3)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Colorectal Neoplasms (Phase 3)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7